Teja Engineering Industries Other Announcement

Teja Engineering Industries H1 FY27 Results: Net Profit ₹5.1 Cr, Up 75.9% YoY

Teja Engineering Industries Ltd reported revenue from operations of ₹50.5 Cr (+50.7% YoY) and net profit of ₹5.1 Cr (+75.9% YoY) for H1 FY27.

Key figure

Net profit ₹5.1 Cr · +75.9% YoY

Teja Engineering Industries Board Meeting Date

Teja Engineering Industries will hold a board meeting on 4 November 2026 to consider unaudited half-yearly standalone results for the period ended September 2026. Trading window is closed until 48 hours after results are declared.

Teja Engineering Industries Board Meeting Outcome

Teja Engineering Industries informed NSE that its board appointed K. J. Tapiawala & Associates as internal auditor and N R Shah & Co as secretarial auditor for FY 2026-27. Both are routine appointments with no monetary value.

Execution

FY 2026-27

Teja Engineering Industries Other Announcement

Teja Engineering Industries filed a non-applicability certificate for Reg 27(2) Corporate Governance for Q1 FY27. As an NSE Emerge-listed SME, the company is exempt from this periodic disclosure.

Teja Engineering Industries Debt & Borrowing: ₹0.3 Cr

Teja Engineering Industries has secured a Rs. 0.30 Crore vehicle loan from Bank of Baroda to purchase a Toyota Innova Hycross for business purposes.

Value

₹0.30 Cr

From

Bank of Baroda

Teja Engineering Industries Board Meeting Outcome

Teja Engineering's board approved a Rs.40 Lacs company car purchase and matching vehicle loan from Bank of Baroda. Remaining items were routine.

Value

₹0.40 Cr

Kansai Nerolac Paints Other Announcement

Kansai Nerolac authorised Pravin Chaudhari, Yash Ahuja and Rukmini Subramanian to determine material events from 1 December 2026. It only lists KMP and contact details.

Glenmark Pharmaceuticals Other Announcement

Glenmark's partner IGI will present updated Phase 1 clinical data for ISB 2001 (ABBV-2001) in relapsed/refractory multiple myeloma at the 68th ASH Annual Meeting. The presentation is scheduled for December 12, 2026.

Vineet Laboratories Other Announcement

Vineet Laboratories' board appointed SVRL & Co. as statutory auditors, subject to shareholder approval. The five-year term runs from the 10th AGM to the 16th AGM.

Physicswallah Other Announcement

Physicswallah's IPO monitoring report flags a deviation from offer objects for the quarter ended September 30, 2026. The diverted funds were restored on October 30, 2026.

Gujarat Kidney and Super Speciality Other Announcement

Gujarat Kidney filed Brickwork's monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation from the IPO fund-utilisation objects.

PDS Other Announcement

PDS Limited submitted the CRISIL Ratings monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation in the utilisation of its QIP proceeds.